Very happy to share our new publication on the role of mitochondrial dynamics in endothelial cells and its implications for whole-body metabolism. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Thank you for inviting me, and for hosting me that well. If you are a vascular biologist, and you are thinking to come next year to IVBM in Adelaide, do not think it twice, this is a vibrant society ❤️!

Australian Network of Cardiac&Vascular Developmental Biologists@ancvdb.bsky.social · 11mo ago

Thrilled to welcome our first plenary speaker Mariona Graupera @grauperalab.bsky.social - beautiful work on endothelial cell plasticity in obesity and PIK3CA-driven vascular malformations

🥳🥳 We have more than 100 abstracts submitted for #GRC_Angiogenesis!!! Application deadline is TOMORROW!! don't miss it!

We have an open postdoc position to work on PTEN and vascular Malformations. If you are intersted, apply: careers.carrerasresearch.org/jobs/6107690...

VAC_53_2025 - POSTDOCTORAL RESEARCH - Institut de Recerca contra la Leucèmia Josep Carreras

Join the Josep Carreras Leukaemia Research Institute and contribute to our mission of innovating and advancing the fight against leukaemia and other hematologic diseases.

careers.carrerasresearch.org

If you are interested in vascular malformations you may want to check our new work published today in Cancer Discovery, where we discover a somatic genetic event causing vascular malformations in PTEN hamartoma tumor syndrome (PHTS) aacrjournals.org/cancerdiscov...

I rising star! I could not be prouder ❤️!

Josep Carreras Leukaemia Research Institute@carrerasijc.bsky.social · 2y ago

🎉 👩‍🔬 Ana Angulo-Urarte (@grauperalab.bsky.social) receives the Junior Leader Retaining grant from "la Caixa" Foundation 🔬 Her research will improve the understanding of how cells with mutations in the PIK3CA gene behave during embryonic development 🔗 www.carrerasresearch.org/en/news/ana-...

EVBO is offering personalised #training for #EVBOmembers for ERC Starting Grant interview. We want EVBO research to be funded by the ERC! If interested, contact Prof. Taija Makinen @ taija.makinen@igp.uu.se by the 25th April. More info: buff.ly/dexAhf7

We are excited to share our work on Context-dependent response of endothelial cells to PIK3CA mutation. A tour the force of many; thank you all for your invaluable contribution. @aangulou.bsky.social @ruibenedito.bsky.social @debocklab.bsky.social @sandradcastillo.bsky.social bit.ly/4blKSqa

Context-dependent response of endothelial cells to PIK3CA mutation

Cancer mutations in the PIK3CA gene cause congenital disorders. The endothelium is among the most frequently affected tissues in these disorders, displaying aberrant vascular overgrowth in the form of...

bit.ly

The freshly cooked video summarizing the Art project developed in the frame of our PIPgen MSCA DN: “PIPgenerating ART: Where Art meet Science “. A collaborative activitys between our students and the Cambridge School of Visual Performing Arts. www.youtube.com/watch?v=tQxA...

PIPgenerating ART: Where Art meet Science

YouTube video by PIPgen

youtube.com

Published a few weeks ago in Cancer Research, we show benefit of targeting HMCR with pitavastatin in combo with AKT inhibitors in TNBC. Many amazing people contributed, led by the magnificently talented @alissandra-hillis.bsky.social! Looking to initiate new clinical trials based on this combo. 🧪

Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer

Two FDA-approved compounds, AKT inhibitors and pitavastatin, synergize to induce cell death in triple-negative breast cancer, motivating evaluation of the efficacy of this combination in clinical tria...

aacrjournals.org

Pls share 🌟Join the IMP as a Group Leader We are 👀 for a colleague, ready to lead a groundbreaking research program. Enjoy generous funding, outstanding facilities & a vibrant scientific community in one of the world's most livable cities @impvienna.bsky.social 👉https://tinyurl.com/impgl2025

Beautiful as always ❤️

Karina Yaniv@karinayaniv.bsky.social · 2y ago

🥳 First Yaniv Lab paper to appear on this new platform!! Thanks Baptiste for the shout-out! 🎉